Careers DiagnosticsOncoE6 Cervical TestA/H5N1 Flu Test Arbor Vita received 510(k) clearance from the U.S. Food and Drug Administration in April 2009 for its rapid diagnostic test... clinical specificity for the test. Testing at NAMRU-3 (U.S. Naval Medical Research Unit No. 3) in Cairo, Egypt demonstrated excellent sensitivity with human H5N1 culture samples. Arbor... Vita is also developing a next generation test for Flu A/Flu B (seasonal flu) that promises to be more sensitive and specific than currently available diagnostics. Using nasal...

Arbor Vita Press Arbor Vita and PATH Receive Phase I SBIR Funding for Cervical Cancer Diagnostic Sunnyvale, CA and Seattle, WAJune 28, 2006Arbor Vita Corporation, a biotechnology... in multiple commercial markets." Bernhard Weigl, PATH diagnostics team leader, agreed with Peter Lu's sentiment. "This work with Arbor Vita is perfectly aligned with PATH's mission... with PATH's Screening Technologies to Advance Rapid Testing (START) project, which seeks to develop low-cost, easy-to-use, culturally acceptable tests for cervical cancer...

Diagnostic Test for Cervical Cancer and Precancerous Lesions Large Study Evaluating Screening Tests Including HPV E6 Test for Cervical Cancer Screening; Interim Findings Presented at 27th... International Papillomavirus Conference in Berlin, Germany Fremont, CASeptember 19, 2011Arbor Vita Corporation, a privately held company developing protein-based diagnostics... who need them most. The START-UP (Screening Technologies to Advance Rapid Testing for Cervical Cancer Prevention-Utility and Program Planning) clinical study is funded by PATH...